The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye
Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the efficacy and safety of 3% Diquafosol Ophthalmic Solution for
visual display terminal (VDT)-associated dry eye and to investigate the mechanism of
treatment.